Detalhe da pesquisa
1.
Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate.
J Infect Dis
; 217(12): 1932-1941, 2018 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29800370
2.
Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.
J Infect Dis
; 215(3): 351-358, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932620
3.
Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2.
mBio
; 14(5): e0081823, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37800919
4.
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity.
Nat Commun
; 14(1): 1371, 2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914616
5.
Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination.
Cell Host Microbe
; 31(11): 1850-1865.e5, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37909048
6.
Vaccine-induced antibodies to contemporary strains of dengue virus type 4 show a mechanistic correlate of protective immunity.
Cell Rep
; 39(10): 110930, 2022 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675766
7.
Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection.
J Clin Invest
; 131(13)2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34003796
8.
Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003).
PLoS Negl Trop Dis
; 15(3): e0009258, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711074
9.
Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine.
Vaccine
; 36(18): 2403-2410, 2018 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29602701